Table 5. The breakdown of the disease clinical stage and successful treatment rate for MTX/FA for the 618 post-molar pregnancy GTT patients.
| Disease site | Patients (%) | Median hCG (IU l−1) | First-line treatment with MTX/FA | First-line MTX/FA success rate (%) |
|---|---|---|---|---|
| hCG only | 58 (9) | 302 | 58 | 74 |
| Uterine vascularity with no mass | 25 (4) | 2388 | 25 | 56 |
| Uterine mass | 467 (76) | 16 571 | 430 | 57 |
| Uterus and adnexae | 7 (1) | 27 019 | 5 | 40 |
| Uterus and lungs | 61 (10) | 24 117 | 39 | 36 |
| Total | 618 | 557 |
Abbreviations: FA=folinic acid; GTT=gestational trophoblastic tumour; GTT=gestational trophoblastic tumour; hCG=human chorionic gonadotropin; MTX=methotrexate.